Comparable stake leader
BlackRock, Inc.
SEC ownership of ARTIVION, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000784199.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
19 Aug 2026
- Public ticker
- AORT on NYSE
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
19 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000784199
- Issuer location
- Kennesaw, GA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ARTIVION, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
19 Aug 2026
13D/G
13F
3/4/5
Lead comparable stake: 13%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 13%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
13%
NOMURA ASSET MANAGEMENT INTERNATI...
6.5%
MORGAN STANLEY
4.4%
PERCEPTIVE ADVISORS LLC
4.3%
Juniper Investment Company, LLC
4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
13%
|
$253,077,358
5,977,264 shares
|
+$1,115,871 | 30 Sep 2025 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13D/G
13F
Company
|
6.5%
|
$71,566,366
3,184,974 shares
|
+$12,841,672 | 30 Jun 2026 |
| MORGAN STANLEY |
13D/G
13F
Company
|
4.4%
|
$87,854,442
2,074,975 shares
|
$0 | 30 Sep 2025 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
4.3%
|
$85,526,800
2,020,000 shares
|
$0 | 30 Sep 2025 |
| Juniper Investment Company, LLC |
13D/G
13F
Company
|
4%
|
$56,474,160
1,864,449 shares
|
$0 | 08 Aug 2025 |
| FMR LLC |
13F
13D/G
Company
|
4%
from 13D/G
|
$44,119,203
1,963,471 shares
|
— | 30 Jun 2026 |
| James P. Mackin |
3/4/5
President & CEO
|
1.8%
|
$25,401,497
877,275 shares
|
-$9,722,502 | 19 Aug 2026 |
| John E. Davis |
3/4/5
Chief Commercial Officer
|
0.47%
|
$8,718,381
230,794 shares
|
-$1,745,900 | 02 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$21,025,330.
Buys
$0
Insiders: 0
Sells
$21,025,330
Insiders: 8
Net
-$21,025,330
Shares: -537,984
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 537,984
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 116,309 | $0 | $3,003,422 | -$3,003,422 |
| 3-6 | 0 | 71,841 | $0 | $2,722,631 | -$2,722,631 |
| 6-9 | 0 | 139,931 | $0 | $5,828,934 | -$5,828,934 |
| 9-12 | 0 | 209,903 | $0 | $9,470,343 | -$9,470,343 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 24 reporting-owner rows connected to ARTIVION, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
24
Largest Forms 3/4/5 holder
James P. Mackin
Net 12M change
-$20,224,112
Latest report
19 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| James P. Mackin | President & CEO | $25,401,497 | -$9,722,502 | -28% | Filing P/S | 19 Aug 2026 |
| John E. Davis | Chief Commercial Officer | $8,718,381 | -$1,745,900 | -17% | Filing P/S | 02 Mar 2026 |
| David Ashley Lee | Executive VP, COO & CFO | $6,655,986 | Mixed | 01 Mar 2023 | ||
| Lance A. Berry | EVP, COO, CFO & Treasurer | $5,998,487 | -$803,205 | -12% | Filing P/S | 14 Aug 2026 |
| Daniel J. Bevevino | Director | $5,772,666 | Mixed | 18 May 2026 | ||
| Thomas F. Ackerman | Director | $5,766,624 | Mixed | 18 May 2026 | ||
| Amy Horton | VP, Chief Accounting Officer | $5,254,132 | -$870,064 | -14% | Filing P/S | 02 Mar 2026 |
| Jean F. Holloway | SVP, General Counsel | $5,245,521 | -$2,537,772 | -33% | Filing P/S | 12 Aug 2026 |
| Jon W. Salveson | Director | $5,032,173 | Mixed | 18 May 2026 | ||
| James Bullock | Director | $2,791,286 | Mixed | 18 May 2026 | ||
| Marshall S. Stanton | SVP, Clinical & MD Affair | $2,270,200 | -$3,426,932 | -60% | Filing P/S | 02 Mar 2026 |
| Jeffrey H. Burbank | Director | $2,247,442 | Mixed | 18 May 2026 | ||
| Ronald D. McCall | Director | $2,191,824 | Mixed | 25 Aug 2021 | ||
| Marna P. Borgstrom | Director | $2,075,035 | Mixed | 18 May 2026 | ||
| Harvey Morgan | Director | $1,747,980 | Mixed | 30 Aug 2021 | ||
| Anthony B. Semedo | Director | $1,741,646 | Mixed | 02 Jun 2026 | ||
| Andrew M. Green | SVP, Regulatory and Quality | $1,702,748 | -$928,325 | -35% | Filing P/S | 14 Aug 2026 |
| Elizabeth A. Hoff | Director | $1,273,094 | -$189,412 | -13% | Mixed | 18 May 2026 |
| Rochelle L. Maney | VP, Quality | $871,883 | Filing P/S | 01 Mar 2024 | ||
| Matthew A. Getz | VP, Human Resources | $863,527 | Filing P/S | 16 Aug 2024 |
Recent insider transactions for ARTIVION, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| James P. Mackin | AORT | Common Stock | Sale | -7.39% | $2,026,850 | $28.96 | -70,000 | 877,275 | 19 Aug 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Sale | -1.02% | $17,586 | $28.55 | -616 | 59,643 | 14 Aug 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -0.34% | $20,413 | $28.55 | -715 | 210,112 | 14 Aug 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -0.53% | $27,835 | $28.49 | -977 | 184,118 | 12 Aug 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Sale | -42.2% | $910,739 | $20.70 | -44,001 | 60,259 | 11 Jun 2026 | Direct |
| Andrew M. Green | AORT | Common Stock | Options Exercise | 95.1% | 44,001 | 90,259 | 11 Jun 2026 | Direct | ||
| Andrew M. Green | AORT | Stock Options (Right to buy) | Options Exercise | -100% | -44,001 | 0 | 11 Jun 2026 | Direct | ||
| Anthony B. Semedo | AORT | Common Stock | Other | 6,325 | 6,325 | 02 Jun 2026 | By the Stacie Nelson and Anthony Semedo Living Trust | |||
| Anthony B. Semedo | AORT | Common Stock | Other | -13.5% | -6,325 | 40,635 | 02 Jun 2026 | Direct | ||
| Marna P. Borgstrom | AORT | Common Stock | Award | 15.4% | 7,576 | 56,664 | 18 May 2026 | Direct | ||
| Anthony B. Semedo | AORT | Common Stock | Award | 19.2% | 7,576 | 46,960 | 18 May 2026 | Direct | ||
| Jon W. Salveson | AORT | Common Stock | Award | 5.83% | 7,576 | 137,416 | 18 May 2026 | Direct | ||
| Elizabeth A. Hoff | AORT | Common Stock | Award | 27.9% | 7,576 | 34,765 | 18 May 2026 | Direct | ||
| Jeffrey H. Burbank | AORT | Common Stock | Award | 14.1% | 7,576 | 61,372 | 18 May 2026 | Direct | ||
| James Bullock | AORT | Common Stock | Award | 11% | 7,576 | 76,223 | 18 May 2026 | Direct | ||
| Daniel J. Bevevino | AORT | Common Stock | Award | 5.05% | 7,576 | 157,637 | 18 May 2026 | Direct | ||
| Thomas F. Ackerman | AORT | Common Stock | Award | 5.05% | 7,576 | 157,472 | 18 May 2026 | Direct | ||
| Marna P. Borgstrom | AORT | Common Stock | Award | 16% | 7,850 | 56,938 | 14 May 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Sale | -4.62% | $340,556 | $38.00 | -8,962 | 185,095 | 04 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Sale | -0.64% | $34,036 | $37.78 | -901 | 139,088 | 03 Mar 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -1.94% | $145,172 | $37.78 | -3,843 | 194,057 | 03 Mar 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -3.45% | $81,180 | $37.78 | -2,149 | 60,097 | 03 Mar 2026 | Direct |
| John E. Davis | AORT | Common Stock | Sale | -1.94% | $172,748 | $37.78 | -4,573 | 230,794 | 03 Mar 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -2.91% | $238,591 | $37.78 | -6,316 | 210,827 | 03 Mar 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -1.85% | $675,692 | $37.78 | -17,887 | 947,275 | 03 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Award | 5.64% | 7,475 | 139,989 | 02 Mar 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Award | 16.3% | 27,795 | 197,900 | 02 Mar 2026 | Direct | ||
| Marshall S. Stanton | AORT | Common Stock | Award | 54% | 21,838 | 62,246 | 02 Mar 2026 | Direct | ||
| John E. Davis | AORT | Common Stock | Award | 14% | 28,845 | 235,367 | 02 Mar 2026 | Direct | ||
| Lance A. Berry | AORT | Common Stock | Award | 23.2% | 40,874 | 217,143 | 02 Mar 2026 | Direct | ||
| James P. Mackin | AORT | Common Stock | Award | 13.8% | 116,948 | 965,162 | 02 Mar 2026 | Direct | ||
| Amy Horton | AORT | Common Stock | Sale | -0.48% | $24,374 | $38.02 | -641 | 132,514 | 02 Mar 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -3.61% | $57,532 | $38.02 | -1,513 | 40,408 | 02 Mar 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Sale | -1.73% | $566,989 | $38.02 | -14,911 | 848,214 | 02 Mar 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Sale | -1.27% | $83,008 | $38.02 | -2,183 | 170,105 | 02 Mar 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Sale | -2.85% | $196,893 | $38.02 | -5,178 | 176,269 | 02 Mar 2026 | Direct |
| John E. Davis | AORT | Common Stock | Sale | -1.33% | $105,861 | $38.02 | -2,784 | 206,522 | 02 Mar 2026 | Direct |
| Amy Horton | AORT | Common Stock | Award | 4.44% | 5,658 | 133,155 | 24 Feb 2026 | Direct | ||
| Amy Horton | AORT | Common Stock | Sale | -0.65% | $29,625 | $35.69 | -830 | 127,497 | 24 Feb 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -2.92% | $44,937 | $35.69 | -1,259 | 41,921 | 24 Feb 2026 | Direct |
| Jean F. Holloway | AORT | Common Stock | Award | 13.2% | 20,085 | 172,288 | 24 Feb 2026 | Direct | ||
| Jean F. Holloway | AORT | Common Stock | Sale | -1.08% | $59,536 | $35.69 | -1,668 | 152,203 | 24 Feb 2026 | Direct |
| James P. Mackin | AORT | Common Stock | Award | 12.7% | 97,030 | 863,125 | 24 Feb 2026 | Direct | ||
| James P. Mackin | AORT | Common Stock | Sale | -1.79% | $497,418 | $35.69 | -13,936 | 766,095 | 24 Feb 2026 | Direct |
| Lance A. Berry | AORT | Common Stock | Award | 26% | 37,482 | 181,447 | 24 Feb 2026 | Direct | ||
| Lance A. Berry | AORT | Common Stock | Sale | -3.02% | $160,083 | $35.69 | -4,485 | 143,965 | 24 Feb 2026 | Direct |
| John E. Davis | AORT | Common Stock | Award | 10.8% | 20,438 | 209,306 | 24 Feb 2026 | Direct | ||
| John E. Davis | AORT | Common Stock | Sale | -1.09% | $74,063 | $35.69 | -2,075 | 188,868 | 24 Feb 2026 | Direct |
| Amy Horton | AORT | Common Stock | Sale | -1.33% | $65,065 | $37.59 | -1,731 | 128,327 | 23 Feb 2026 | Direct |
| Marshall S. Stanton | AORT | Common Stock | Sale | -5.31% | $91,076 | $37.59 | -2,423 | 43,180 | 23 Feb 2026 | Direct |
* marks a reported price that did not pass the local price check.